Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study.

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126221. Date of Electronic Publication: 2024 Aug 24.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in Qatar.

  • Authors : Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control SARS-CoV-2 variants

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Oct; Vol. 18 (10), pp. e13357.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic)

Record details

×
Academic Journal

Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/epidemiology SARS-CoV-2 variants

  • Source: Immunology letters [Immunol Lett] 2024 Oct; Vol. 269, pp. 106903. Date of Electronic Publication: 2024 Jul 26.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7910006 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effects of the induction of humoral and cellular immunity by third vaccination for SARS-CoV-2.

  • Authors : Murayama G; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan. Electronic address: .; Kusaoi M

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology

  • Source: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Oct; Vol. 30 (10), pp. 1021-1027. Date of Electronic Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children below 5 years of age in Germany (CoVacU5): a retrospective cohort study.

  • Authors : Moor J; CLINTEC Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden.; Toepfner N

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Biology of sex differences [Biol Sex Differ] 2024 Sep 26; Vol. 15 (1), pp. 74. Date of Electronic Publication: 2024 Sep 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101548963 Publication Model: Electronic Cited Medium: Internet ISSN: 2042-6410

Record details

×
Academic Journal

Proton pump inhibitors associated with severe COVID-19 among two-dose but not three-dose vaccine recipients.

  • Authors : Cheung KS; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.; Yan VKC

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2024 Sep; Vol. 39 (9), pp. 1837-1846. Date of Electronic Publication: 2024 May 05.Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Waning Humoral Immune Response Following the Third and Fourth SARS-COV-2 Vaccine: A Cohort Study in Healthcare Workers.

  • Authors : Süner AF; Department of Public Health, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.; Ergör G

Subjects: Health Personnel* ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Sep; Vol. 18 (9), pp. e70003.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic)

Record details

×
Academic Journal

Comparative effectiveness and safety of BNT162b2 and CoronaVac in Hong Kong: A target trial emulation.

  • Authors : Wan EYF; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D(2)4H), Hong Kong Science and Technology Park, Hong Kong SAR, China

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/mortality

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Sep; Vol. 146, pp. 107149. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
Academic Journal

First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial.

  • Authors : Poh XY; National Centre for Infectious Diseases, Singapore.; Lee IR

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology COVID-19 breakthrough infectionsSARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2024 Sep; Vol. 107, pp. 105275. Date of Electronic Publication: 2024 Aug 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Sep; Vol. 146, pp. 107111. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
  • 1-10 of  3,800 results for ""BNT162 Vaccine""